Sanofi-Aventis to invest in R&D in Spain
Business Investments
01 Apr 2012
France-based pharmaceutical company Sanofi-aventis plans to invest $1.3 million in research and development (R&D) projects of Barcelona's international biomedical research institute CRG.
The projects include cell reprogramming, the application of synthetic biology technology to treat lung diseases, the influence of genes as factor for some diseases and tuberculosis treatment, the director of CRG, Luis Serrano, said.
Source: IPA WORLD, 8/3/2012
Related News and Success stories.
-
01 Jul 2025
See more New direct flight to boost ties between Canada and CataloniaNew direct flight to boost ties between Canada and Catalonia
-
30 Jun 2025
See more PreZero invests €42M in Barcelona to launch Spain’s largest SRF plant and first urban biomethane facilityPreZero invests €42M in Barcelona to launch Spain’s largest SRF plant and first urban biomethane facility
-
20 Jun 2025
See more Trend Micro chooses Barcelona to open its new European Cybersecurity HubTrend Micro chooses Barcelona to open its new European Cybersecurity Hub
-
18 Jun 2025
See more Catalonia strengthens global biotech ties at BIO Boston 2025 with major networking eventCatalonia strengthens global biotech ties at BIO Boston 2025 with major networking event
